Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.



LENS trial  of fibrates in patients with diabetes and observable retinopathy commences

Article published in EHJ by European Atherosclerosis Society Consensus Panel: "Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract"


Article by Fausto Pinto (ESC President 2014-16): Cholesterol and statins: why fear the truth?

REVEAL trial results announced at ESC: effects of Anacetrapib in patients with atherosclerotic vascular disease

CANTOS trial results: study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack

AMS report: how can we all best use scientific evidence?

FOURIER trial results published: inhibition of PCSK9 with evolocumab on a background of statin therapy


LSHTM StatinWISE trial assessing muscle symptoms recruits first patients

ASCOT-LLA publishes adverse event analyses

The Lancet publishes major review about the use of statins

Impact of renal function on the effects of LDL-cholesterol lowering with statin-based regimens

Renewed call to retract BMJ articles that mislead on statin effects

Adverse impact on public health of misleading information about statin safety

Adverse event protocol published in AHJ

Tabular data (all Serious Adverse Events by MedDRA classification) now available for HPS and SEARCH


Adverse event protocol finalised and submitted

Statin treatment reduces the risk of cardiovascular disease in women


Misrepresentation of statin safety evidence in letter by Thompson et al to NICE: Lancet article and annotated version of NICE letter


Wider statin use in healthy people could save 2,000 lives a year in the UK


More intensive statin treatment leads to greater reductions in the risk of major cardiovascular events than regular doses


Specific benefits of statins identified